Literature DB >> 4120302

Loss of isoantigens A, B and H in prostate.

R K Gupta, R Schuster, W D Christian.   

Abstract

Formalin-fixed tissues from 65 prostates were grouped and investigated by the technic of mixed cell agglutination reaction (MCAR) for studying isoantigens A, B and H. The results of this study indicated that the MCAR was strongly positive at the epithelium of the acini in the majority of patients with benign prostatic hyperplasia. On the other hand, patients with primary carcinomas and metastatic carcinomas of prostates were found to be uniformly negative for any agglutination reaction. Prostates from a group of younger individuals only showed a patchy distribution of the MCAR at the epithelium of the acini. In view of these findings, it seemed that the traces of isoantigens in normal prostates show a considerable increase when the disease process of BPH becomes manifest in this organ, while in cases of primary and metastatic carcinomas the isoantigens are totally lost. In the light of previous studies on similar lines, the various possible mechanisms for this sudden transition are discussed.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4120302      PMCID: PMC1904009     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  6 in total

1.  THE DEMONSTRATION AND DISTRIBUTION OF WATER SOLUBLE BLOOD GROUP O (H) ANTIGEN IN TISSUE SECTIONS USING A FLUORESCEIN LABELLED EXTRACT OF ULEX EUROPEUS SEED.

Authors:  S P KENT
Journal:  J Histochem Cytochem       Date:  1964-08       Impact factor: 2.479

2.  BLOOD GROUP SPECIFIC SUBSTANCES IN HUMAN GASTRIC CARCINOMA. A STUDY USING THE FLUORESCENT ANTIBODY TECHNIQUE.

Authors:  A E EKLUND; B GULLBRING; B LAGERLOEF
Journal:  Acta Pathol Microbiol Scand       Date:  1963

3.  A, B, and O substances in gastrointestinal carcinoma.

Authors:  I Davidsohn; S Kovarik; C L Lee
Journal:  Arch Pathol       Date:  1966-05

4.  Loss of isoantigens A, B, and H in carcinoma of the lung.

Authors:  I Davidsohn; L Y Ni
Journal:  Am J Pathol       Date:  1969-11       Impact factor: 4.307

5.  ABO antigens in cancer. Detection with the mixed cell agglutination reaction.

Authors:  S Kovarik; I Davidsohn; R Stejskal
Journal:  Arch Pathol       Date:  1968-07

6.  Isoantigens A, B, and H in benign and malignant lesions of the cervix.

Authors:  I Davidsohn; S Kovarik; L Y Ni
Journal:  Arch Pathol       Date:  1969-03
  6 in total
  8 in total

1.  Isoantigens A, B and H in benign and malignant lesions of breast.

Authors:  R K Gupta; R Schuster
Journal:  Am J Pathol       Date:  1973-08       Impact factor: 4.307

2.  ABH antigenicity of in situ carcinoma of the urinary bladder during intracavity treatment with doxorubicin hydrochloride.

Authors:  G Jakse; F Hofstädter
Journal:  Urol Res       Date:  1981

3.  Mechanisms of action of intravesical treatment. Effect on the ABH surface antigens of urothelial cells.

Authors:  G Jakse; F Hofstädter
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

4.  Human semen as a source of epithelial cells for culture.

Authors:  S G Phillips; D M Phillips; E A Kabat; O J Miller
Journal:  In Vitro       Date:  1978-08

5.  Deletion of antigens of the Lewis a/b blood group family in human prostatic carcinoma.

Authors:  W W Young; S E Mills; M C Lippert; P Ahmed; S K Lau
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307

6.  Biological tissue markers in benign and malignant disease of the human prostate.

Authors:  P Chastonay; J Hurlimann; D Gardiol
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

7.  Are blood group isoantigens lost from malignant prostatic epithelium? Immunohistochemical support for the preservation of the H isoantigen.

Authors:  P Vowden; A D Lowe; E S Lennox; N M Bleehen
Journal:  Br J Cancer       Date:  1986-03       Impact factor: 7.640

8.  The expression of ABH and Y blood group antigens in benign and malignant breast tissue: the preservation of the H and Y antigens in malignant epithelium.

Authors:  P Vowden; A D Lowe; E S Lennox; N M Bleehen
Journal:  Br J Cancer       Date:  1986-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.